Blanpain C, Buser R, Power C A, Edgerton M, Buchanan C, Mack M, Simmons G, Clapham P R, Parmentier M, Proudfoot A E
IRIBHN Université Libre de Bruxelles, Campus Erasme, Bruxelles, Belgium.
J Leukoc Biol. 2001 Jun;69(6):977-85.
Human RANTES (CCL5) and MIP-1alpha (CCL3) bind and activate several CC chemokine receptors. RANTES is a high-affinity ligand for CCR1 and CCR5, and it binds CCR3 with moderate affinity and CCR4 with low affinity. MIP-1alpha has similar binding characteristics to RANTES except that it does not bind to CCR3. Here we have generated a chimera of human MIP-1alpha and RANTES, called MIP/RANTES, consisting of the eight amino terminal residues of MIP-1alpha preceding the CC motif, and the remainder of the sequence is RANTES. The chimera is able to induce chemotaxis of human monocytes. MIP/RANTES has >100-fold reduction in binding to CCR1 and does not bind to CCR3 but retains full, functional binding to CCR5. It has equivalent affinity for CCR5 to MIP-1alpha and RANTES, binding with an IC(50) of 1.12 nM, and is able to mobilize calcium and induce endocytosis of CCR5 in PBMC in a manner equi-potent to RANTES. It also retains the ability to inhibit R5 using HIV-1 strains. Therefore, we conclude that the amino terminus of RANTES is not involved in CCR5 binding, but it is essential for CCR1 and CCR3.
人RANTES(CCL5)和MIP-1α(CCL3)可结合并激活多种CC趋化因子受体。RANTES是CCR1和CCR5的高亲和力配体,它与CCR3的结合亲和力中等,与CCR4的结合亲和力较低。MIP-1α具有与RANTES相似的结合特性,只是它不与CCR3结合。在此,我们构建了一种人MIP-1α与RANTES的嵌合体,称为MIP/RANTES,它由CC基序之前的MIP-1α的八个氨基末端残基组成,其余序列为RANTES。该嵌合体能够诱导人单核细胞的趋化性。MIP/RANTES与CCR1的结合能力降低了100倍以上,且不与CCR3结合,但保留了与CCR5的完全功能性结合。它对CCR5的亲和力与MIP-1α和RANTES相当,结合的半数抑制浓度(IC50)为1.12 nM,并且能够以与RANTES相当的效力在PBMC中动员钙离子并诱导CCR5的内吞作用。它还保留了使用HIV-1毒株抑制R5的能力。因此,我们得出结论,RANTES的氨基末端不参与与CCR5的结合,但对CCR1和CCR3至关重要。